Piracetam dosage and dilution
Piracetam dosage dilution IV administration clinical
https://www.e-lactancia.org/media/papers/Piracetam-DS-UCB201…
https://db.cbg-meb.nl/veegactie/csp/piracetam-6-2010.pdf
| Form | Strength |
|---|---|
| Film-coated tablets | 800 mg, 1200 mg |
| Oral solution | 20% (200 mg/ml), 33% (333 mg/ml) |
| Injection ampoules | 3 g / 15 ml |
| Diluent | Concentrations |
|---|---|
| Glucose | 5%, 10%, 20% |
| Fructose | 5%, 10%, 20% |
| Sodium Chloride 0.9% (Normal Saline) | - |
| Dextran 40 (10% in 0.9% NaCl) | - |
| Ringer solution | - |
| Mannitol 20% | - |
| HES (Hydroxy Ethyl Starch) 6% and 10% | - |
No known incompatibilities with the above diluents.
| Renal Function | CrCl (ml/min) | Dose Adjustment | Frequency |
|---|---|---|---|
| Normal | >80 | Full usual dose | 2-4 divided doses |
| Mild impairment | 50-79 | 2/3 usual dose | 2-3 divided doses |
| Moderate impairment | 30-49 | 1/3 usual dose | 2 divided doses |
| Severe impairment | <30 | 1/6 usual dose | Single daily dose |
| End-stage renal disease | - | Contraindicated | - |
CrCl = [140 - age(years)] × weight(kg) × (0.85 if female) / [72 × serum creatinine (mg/dl)]| Population | Consideration |
|---|---|
| Elderly | Half-life prolonged due to reduced renal function - monitor CrCl regularly for long-term use |
| Pregnancy | Avoid unless benefit clearly outweighs risk; crosses placental barrier |
| Pediatrics | No formal PK studies; use weight-based dosing (mg/kg) as above |